Viimane versioon :
18/04/2024
Uurimisrühmad - University of Exeter   Pdf  
Suurbritannia
ülikool
University of Exeter
Exeter
Email
Viited   Viited   (7)  
1
Stability studies on admixtures of 5-fluorouracil with carboplatin and 5-fluorouracil with heparin for administration in continuous infusion regimens.
Sewell GJ, Allsopp M, Collinson MP, Tyrrell C, Prentice AJ, Copplestone JA. ()
J Clin Pharm Ther - 1994 - ; 19: 127-133.
4
The degradation of carboplatin in aqueous solutions containing chloride or other selected nucleophiles.
Allsopp M.A, Sewell G.J, Rowland C.G, Riley C.M, Schowen R.L. ()
Int J Pharm - 1991 - ; 69: 197-210.
5
The formulation and stability of a unit-dose oral vitamin K1 preparation.
Sewell GJ, Palmer AJ. ()
J Clin Pharm Ther - 1988 - ; 13, 1: 73-76.
6
The stability of carboplatin in ambulatory continuous infusion regimes.
Sewell GJ, Riley CM, Rowland CG. ()
J Clin Pharm Ther - 1987 - ; 12: 427-432.
7
The stability of sodium nitroprusside infusion during administration by motorized syringe-pump.
Sewell GJ, Forbes DR, Munton TJ. ()
J Clin Hosp Pharm - 1985 - ; 10: 351-360.

Ingredientide nimekiri   Molekulid uuritud   (10)  
Vähiravimite Süsteravim Carboplatin
Analgeetikum Süsteravim Diamorphine hydrochloride
Antibiootikum Süsteravim Erythromycin lactobionate
Vähiravimite Süsteravim Fluorouracil
Antibiootikum Süsteravim Fusidate sodium
Antikoagulant Süsteravim Heparin sodium
Põletikuvastane ravim Süsteravim Methylprednisolone sodium succinate
Vähiravimite Süsteravim Mitoxantrone dihydrochloride
Vasodilataator Süsteravim Nitroprusside sodium
Vitamiin Suukaudne lahus Phytomenadione

  Mentions Légales